The Obesity Vaccine

Scientists are advocating altering the mental states of humans to control their consumptive tendencies


The attack on the overweight has kicked into high gear, as the pharmaceutical corporations seek out an immunization to answer the American weight problem.

Last month the UN’s World Health Organization (WHO) announced that because of over-population and over-consumptive cultures, Americans have become overweight . . . and that is a problem.

Working with WHO, researchers at the BMC Public Health have published a study regarding the increasing levels of “fatness” worldwide and the impact such weight gain has on global resources. They contend that over-weight people are likening to an extra billion humans born on the planet.

The target of these researchers is North America, specifically the American population. Although Americans only account for 6% of the global population, more than a third of them are considered obese. They contend a new social meme concerning consumption, weight and population growth called “globesity” must be introduced to combat this new problem.

Prof Charles Godray from the Martin School at the University of Oxford, who chaired the process of writing the declaration , says “The overall message is that we need a renewed focus on both population and consumption – it’s not enough to look at one or the other. We need to look at both, because together they determine the footprint on the world.”

The UN blames “rapid unplanned urbanization” and the “globalization of unhealthy lifestyles” as the culprits of the obesity epidemic. The UN also declares that the cost of overweight and obese individuals in a drain on our global economy; and a burden indicative of large, affluent societies, like America.

A new study published in the Journal of Animal Science and Biotechnology, claims that vaccines are the answer to the chemical and psychological issues that surround obesity. The co-author of the study was also the president and chief scientific officer of a company called Braasch Biotech LLC. Braasch Biotech LLC, which specializes in the development of human and animal vaccines. Essentially, by inhibiting natural hormones, researchers hope to stop people from eating.

Big Pharma have created one-in-all vaccines before, i.e. the universal flu shot that was meant to entice the public back into a regular immunization schedule. However, this is not just about poisoning the public through vaccinations; the drug corporations see the obesity market as an untapped monetary resource – as one executive explained: “Can you imagine the potential for vaccines?”

Scientists assert that somatostatin, a peptide hormone, inhibits the action of growth hormone and insulin-like growth factor, both of which increase metabolism and result in weight loss. The vaccine would modify somatostatin by engineering so that the chemical inhabitation is removed and antibodies are created against somatostatin.

Because somatostatin is secreted in the digestive system, the hormone would eventually be carried to the brain where it would have a great likelihood of interacting with the chemical makeup of the brain and thereby have an encompassing psychological reaction.

When studied in mice , somatostatin:

  • Mice who were given the vaccines experienced an initial drastic loss of weight but then gained weight over the course of six weeks – just not as quickly as the mice in the control group.
  • The weight loss after the first dose of vaccine was so drastic that the dose used in the second injection in the study was reduced out of concern for the mice’s health.
  • If the volume of vaccine given to the mice was scaled up it would be equivalent to over a litre for an average sized adult – a much greater volume than is usually used in a vaccination.

The reduction of the body’s production of ghrelin decreases hunger thereby reduces caloric intake and increases stored calories being used. This finding was presented at The Endocrine Society’s 93rd Annual Meeting in Boston.

Mariana Monteiro, MD, PhD, an associate professor at the University of Porto in Portugal and lead researcher in the study said: “An anti-ghrelin vaccine may become an alternate treatment for obesity, to be used in combination with diet and exercise.”

By reducing the effects of neuropeptides that control appetite, researchers show that obesity can be controlled. Simply put, scientists are advocating altering the mental states of humans to control their consumptive tendencies.

The effects of such a chemical alteration on humans have not been completely studied prior to the praise of this new finding. “This study demonstrates the possibility of treating obesity with vaccination”, says one of the authors of the study. “Although further studies are necessary to discover the long term implications of these vaccines, treatment of human obesity with vaccination would provide physicians with a drug- and surgical- free option against the weight epidemic.”

Doctors have been admonished by the government panel, entitled the US Preventative Services Task Force (USPSTF), to become Natazi and coerce their patients into controlling their body mass index (BMI); while even suggesting pharmacological answers to obesity issues.

Arena Pharmaceuticals have developed lorcaserin, which works against serotonin receptors that correlate with appetite signals in the brain and cause the patient to become less hungry. Touted as a medical enhancement to type 2 diabetes treatments, it reduced the weight of participants in clinical trials by 5 – 10%.

The American Medical Association (AMA) announced this week that high school children will be required to attend classes that will discuss the causes, consequences and prevention methods of obesity. Taxes derived from purchases of sodas may be used to pay for these programs, suggests the AMA. However, the AMA still says they do not support taxing the public.

Articles by: Susanne Posel

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]